Investments and fair value measurements (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Investments on Condensed Consolidated Balance Sheets

The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of March 31, 2024	Level 1		Level 2		Level 3
Current assets:
Cash equivalents:
Money market funds	$	217,979	$	—	$	—
Marketable securities:
U.S. government securities	$	—	$	173,883	$	—
Non-current assets:
Strategic investments	$	—	$	—	$	10,311
Non-current liabilities:
Cash settled stock appreciation rights	$	—	$	—	$	22

As of December 31, 2023	Level 1		Level 2		Level 3
Current assets:
Cash equivalents:
Money market funds	$	266,692	$	—	$	—
Marketable securities:
U.S. government securities	$	—	$	171,372	$	—
Non-current assets:
Strategic investments	$	—	$	—	$	10,311
Non-current liabilities:
Cash settled stock appreciation rights	$	—	$	—	$	48

Schedule of Investments on Condensed Consolidated Balance Sheets

The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of March 31, 2024	Level 1		Level 2		Level 3
Current assets:
Cash equivalents:
Money market funds	$	217,979	$	—	$	—
Marketable securities:
U.S. government securities	$	—	$	173,883	$	—
Non-current assets:
Strategic investments	$	—	$	—	$	10,311
Non-current liabilities:
Cash settled stock appreciation rights	$	—	$	—	$	22

As of December 31, 2023	Level 1		Level 2		Level 3
Current assets:
Cash equivalents:
Money market funds	$	266,692	$	—	$	—
Marketable securities:
U.S. government securities	$	—	$	171,372	$	—
Non-current assets:
Strategic investments	$	—	$	—	$	10,311
Non-current liabilities:
Cash settled stock appreciation rights	$	—	$	—	$	48